| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |